Skip to content

TYRA BIOSCIENCES, INC.

TYRA

CIK 0001863127

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$125.42M
−38.7% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.08
−33.1% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$90.18M
Q1 May 2026
Cash
$84.96M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
59.47M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings